Syros Pharmaceuticals
(OTC) SYRS
Syros Pharmaceuticals Financials at a Glance
Market Cap
$8,000
Revenue (TTM)
$386.00K
Net Income (TTM)
$97.81M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
5.67 (High)
Dividend
$0.00
Beta (Volatility)
5.67 (High)
Price
$0.00
Volume
238
Open
$0.00
Price
$0.00
Volume
238
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.04
Dividend
$0.00
Beta (Volatility)
5.67 (High)
Price
$0.00
Volume
238
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.04
SYRS News
SYRS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Syros Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
68
CEO
Conley Chee, MBA; Nancy A. Simonian, MD
Website
www.syros.comHeadquarters
Cambridge, MA 02140, US
SYRS Financials
Key Financial Metrics (TTM)
Gross Margin
77%
Operating Margin
-13%
Net Income Margin
-17%
Return on Equity
0%
Return on Capital
-98%
Return on Assets
-98%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.00K
Shares Outstanding
26.83M
Volume
238
Short Interest
0.00%
Avg. Volume
27.94K
Financials (TTM)
Gross Profit
$7.68M
Operating Income
$128.99M
EBITDA
$157.19M
Operating Cash Flow
$109.71M
Capital Expenditure
$272.00K
Free Cash Flow
$109.98M
Cash & ST Invst.
$139.53M
Total Debt
$62.08M
Syros Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$325.00K
-110.3%
Gross Margin
0.00%
N/A
Market Cap
$8.00K
N/A
Market Cap/Employee
$117.65
N/A
Employees
68
N/A
Net Income
$6.40M
+84.1%
EBITDA
$4.76M
+87.5%
Quarterly Fundamentals
Net Cash
$1.95M
-104.1%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$57.64M
-1.6%
Short Term Debt
$2.58M
-58.0%
Return on Assets
-97.86%
N/A
Return on Invested Capital
-98.09%
N/A
Free Cash Flow
$20.69M
+35.1%
Operating Cash Flow
$20.69M
+35.1%